CIK 0001599298 · Large accelerated filer
Summit Therapeutics Inc.
Sign in to watch- Ticker
- SMMT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 371979717
- Phone
- 305-203-2034
- Business address
- 601 BRICKELL KEY DRIVE, SUITE 1000, MIAMI, FL, 33131
- Former names
- Summit Therapeutics plc, Summit Corp plc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 8 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-02-19 | Soni Manmeet Singh Director | Grant or award · Stock Option (right to buy) | +25,000 | 252,273 | ||
| 2021-02-19 | Erdtmann Rainer M Director | Grant or award · Stock Option (right to buy) | +25,000 | 252,273 | ||
| 2021-02-19 | Donaldson Michael Paul Chief Financial Officer | Returned to the company · Stock Option (right to buy) | −5,110 | 594,890 |
Page 9 of 9 · 163 trades